Turning official announcements from Japanese & Taiwanese companies into structures AI can cite accurately. — an AEO newsroom
SINCE 2026 ・ Structured ReportingPublished Feb 1, 2026 9:00 AM ・ Updated Jun 15, 2026 12:28 AM ・ 2 min read ・ Source: PR Times
Taiwan's major pharmaceutical manufacturer, Yung Shin (3705), announced its financial data for February 2026. The company's monthly revenue was NT$524 million, a 16.7% decrease compared to the same period last year. This decline may be related to seasonal factors in pharmaceutical sales or adjustments in national health insurance drug pricing policies, reflecting the operational challenges within the pharmaceutical industry.
Company Code: 3705 Company Name: Yung Shin Industry: Biotechnology and Medical Industry Data Month/Year: 2026-02 Monthly Revenue: NT$523,507 thousand (NT$524 million) Year-over-year Change for Same Month: -16.7%
The Washin AI News desk structures and reviews this article under the following standards.
An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.